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Abstract
Background: Anorectal malformations (ARM) are rare forms of congenital uro-rectal anomalies with largely
unknown causes. Besides genetic factors, prenatal exposures of the parents to nicotine, alcohol, caffeine, illicit
drugs, occupational hazards, overweight/obesity and diabetes mellitus are suspected as environmental risk factors.
Methods: Relevant studies published until August 2010 were identified through systematic search in PubMed,
EMBASE, ISI Web of Knowledge and the Cochrane Library databases. Furthermore, related and cross-referencing
publications were reviewed. Pooled odds ratios (95% confidence intervals) were determined to quantify
associations of maternal and paternal smoking, maternal alcohol consumption, underweight (body mass index
[BMI] < 18.5), overweight (BMI 25-29.9), obesity (BMI ≥30) and maternal diabetes mellitus with ARM using meta-
analyses.
Results: 22 studies that reported on the association between prenatal environmental risk factors and infants born
with ARM were included in this review. These were conducted in the United States of America (n = 12), Spain
(n = 2), Sweden (n = 2), the Netherlands (n = 2), Japan (n = 1), France (n = 1), Germany (n = 1) and Hungary
(n = 1). However, only few of these studies reported on the same risk factors. Studies were heterogeneous with
respect to case numbers, control types and adjustment for covariates. Consistently increased risks were observed
for paternal smoking and maternal overweight, obesity and diabetes, but not for maternal smoking and alcohol
consumption. In meta-analyses, pooled odds ratios (95% confidence intervals) for paternal smoking, maternal
overweight, obesity, pre-gestational and gestational diabetes were 1.53 (1.04-2.26), 1.25 (1.07-1.47), 1.64 (1.35-2.00),
4.51 (2.55-7.97) and 1.81 (1.23-2.65), respectively.
Conclusion: Evidence on risk factors for ARM from epidemiological studies is still very limited. Nevertheless, the
few available studies indicate paternal smoking and maternal overweight, obesity and diabetes to be associated
with increased risks. Further, ideally large-scale multicentre and register-based studies are needed to clarify the role
of key risk factors for the development of ARM.
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Introduction
In recent years, a number of studies have shown that
prenatal exposures of the parents are associated with an
increased risk for having a malformed child. However,
only few studies exist regarding the association with
anorectal malformations (ARM).
ARM are rare birth defects concerning anus and rec-
tum. Approximately 1 in 2,500 to 1 in 5,000 new born
babies are affected [1-3]. Different degrees of severity
are distinguished, ranging from mild anal stenosis over
anal atresia with or without fistula to persistent cloaca
or even cloacal exstrophy [4]. Furthermore, ARM fre-
quently manifest with other malformations. Approxi-
mately 64% of all ARM patients are affected and have
one or more additional extra-anal anomalies [5]. Pre-
vious studies have shown that associated malformations
a r em o r ef r e q u e n ti n“high” defects that are complex
and difficult to manage with a poor functional prognosis
than in “low” defects that are less complex and easily
treated with an excellent functional prognosis. Asso-
ciated malformations mainly include the genitourinary
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(5-40%), the rest of the gastrointestinal tract (10-25%)
and the heart (9-20%) [6]. Anorectal malformations
affect several socioeconomic and ethnic groups [7-11].
Boys seem to be at a slightly higher risk than girls
(1.3:1) [12]. It is assumed that the defects occur during
the 4th to 8th week of fetal development [13-18]. Cur-
rent knowledge about the causes, however, is still sparse.
In addition to genetic factors, prenatal exposures of the
parents to tobacco, alcohol, caffeine, illicit drugs, over-
weight/obesity, diabetes mellitus and occupational
hazards are subject to ongoing debate as potential envir-
onmental risk factors, in particular because the few
existing studies are based on retrospectively collected
data from individual centers only.
We conducted a systematic review and meta-analysis
of epidemiological studies to summarize current evi-
dence on the relationship between parental risk factors
and anorectal malformations and to identify knowledge
deficits that need to be addressed in future research.
Methods
Identification of studies and study selection
A literature search was carried out to identify epidemiolo-
gical studies assessing the association between seven pre-
natal exposures of parents that have been suggested to be
environmental risk factors for anorectal malformations:
smoking, alcohol, caffeine, illicit drugs, overweight/obesity,
diabetes and occupational hazards. Relevant studies pub-
lished in English were systematically searched in PubMed,
EMBASE, ISI Web of Knowledge and the Cochrane
Library databases by using various combinations of the fol-
lowing terms: (congenital malformation(s), congenital
abnormality, congenital abnormalities, birth defect(s),
anorectal malformation(s), anorectal atresia, anal atresia,
imperforate anus) AND (smok*, nicotine, tobacco, cigar-
ette*, alcohol*, drink*, caffeine*, coffee*, illicit drug(s), drug
(s), overweight, obesity, adiposity, diabetes (mellitus), dia-
betes type 2, diabetes type 1, type 2 diabetes, type 1 dia-
betes, gestational diabetes, pre-gestational diabetes, pre-
existing diabetes, occupational hazard(s), occupational risk
(s), professional risk(s), job hazard(s), parental occupation,
maternal occupation, paternal occupation). Duplicate arti-
cles were deleted. Each title and abstract was checked for
relevance. The full text was reviewed if the abstract indi-
cated that the article reported an association between
ARM and one of the previously mentioned risk factors.
Furthermore, the identified articles were reviewed for
related articles and cross-referring publications.
Inclusion criteria
Articles were included if they reported on associations
of anorectal malformations with at least one of the pre-
viously mentioned environmental risk factors. When
available, data of ARM infants with isolated anomalies
(no additional major defects) were preferred to data of
ARM infants with multiple defects. Articles were
excluded if the reported number of ARM cases was less
than two. ARM infants analysed only in a group with
other anomalies like intestinal or tracheo-esophageal
atresias were also excluded because of concern that
associations of risk factors with these anomalies might
be different from associations with ARM. Searches were
restricted to English-language articles.
Data extraction
Two reviewers independently assessed the articles and
extracted the following key information in a standardized
manner: first author, year, country, study design, charac-
teristics of the study population, period of data acquisition,
assessed risk factor(s) for ARM and the respective mea-
sures of odds ratio or prevalence ratio (see below), as well
as covariates adjusted for in the analysis. Initial disagree-
ments on classifications of study characteristics were
resolved by discussion within the team of authors.
Associations between parental exposures and ARM are
presented by odds ratios (OR) and their 95% confidence
intervals (CI). Alternatively, reported prevalence ratios
(PR) are shown. Unadjusted values were recalculated by
the Review Manager Software, version 5.0.24 (The Ger-
man Cochrane Centre, Freiburg, Germany) to validate
the results. When measures of associations were not
explicitly reported, they were derived from data pro-
vided in the articles.
Meta-analyses
Meta-analyses were performed for risk factors for which
results were available from at least two studies. Heteroge-
neity was assessed by the c² and I² statistics. When the
number of studies is low or when sample sizes are small,
the power of the c² test is low. The I² measure describes
the proportion of total variation in effect estimates across
studies that is due to heterogeneity rather than sampling
error [19]. Fixed and random effects models were calcu-
lated by the R
© software, version 2.11.1 (The R Founda-
tion for Statistical Computing, Vienna) using standard
meta-analysis methods. The fixed effects model was used
to estimate the variance of the summary odds ratio when
study heterogeneity was low (I²≤ 25) and the random
effects model when study heterogeneity was moderate to
high (I²> 25) [20,21]. Indication of publication bias was
assessed by Begg and Mazumdar rank correlation test
[22] and Egger’s test [23] (P < 0.1).
Results
Literature search result
In total, 9,623 articles were found (figure 1). After
removal of 3,475 duplicates, 6,148 titles and abstracts
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Page 2 of 16were reviewed. Thirty-one articles appeared to be poten-
tially relevant for inclusion in the review. Of these, four
articles were excluded because of too low case numbers
(n < 2), three articles because they referred to results of
already selected articles and further two articles because
they reported on ARM cases analysed in a group with
other anomalies. Finally, 22 articles were included in the
review. Among the included studies, eight provided data
on the association of ARM with prenatal exposures to
smoking, four to alcohol consumption, one to caffeine
Total: n = 9,623
Titles and abstracts reviewed: n = 6,148
Duplicate articles excluded: 
n = 3,475
PubMed search:  
n = 5,197 
EMBASE search: 
n = 2,554
Included articles: n = 22 
Not relevant to review topic:
n = 6,117
Selected articles: n = 31 
Low case number: n = 4
Articles that reported on ARM 
cases analysed in a group with 
other anomalies: n = 2 
Cochrane library 
search: n = 12
Smoking: n = 8
Alcohol: n = 4
Caffeine intake: 
n = 1
Overweight/Obesity: 
n = 3
Diabetes: n = 8
Occupational 
hazard: n = 5
Illicit drugs: n = 2
Articles that refer to results of 
already selected articles: n = 3 
ISI search: 
n = 1,860
Figure 1 Flow diagram of the literature search process.
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sity, eight to diabetes mellitus and five to occupational
hazards.
Studies included in this review
Details on the 22 studies, which were published from
1981 to June 2010, are shown in table 1. Studies were
mainly conducted in the USA (n = 12). The remaining
studies were conducted in Spain (n = 2), Sweden (n =
2), the Netherlands (n = 2), Japan (n = 1), France (n =
1), Germany (n = 1) and Hungary (n = 1). Recruitment
was population-based in 16 studies and hospital-based
in six studies. For data acquisition, nine studies relied
on register-based data [1,7,24-30]. Data acquisition peri-
ods varied from one year [31] to 29 years [32].
Case numbers ranged from 14 ARM cases [33] to 564
ARM cases [31]. Children with known chromosomal
anomalies were excluded in nine studies [26,27,34-40].
Twelve studies used healthy newborns or infants with no
m a j o rb i r t hd e f e c t sa sc o n t r o lgroup [7,25,28-30,34,35,37-41]
and seven studies used malformed infants with other
anomalies than ARM [24,27,32,33,36,42,43]. Controls of
the remaining three studies were all infants born in the
same settings during the respective study period
[1,26,31]. Only six studies examined ARM infants with
isolated anomalies [7,30,34,37,38,40].
Findings for the reviewed risk factors
Study results as well as the covariates adjusted for are
shown in tables 2 to 8.
Cigarette consumption
Seven studies reported on the association between
maternal smoking before or during pregnancy and
infants born with an anorectal malformation (table 2).
Any smoking during pregnancy was significantly asso-
ciated with ARM only in the study by Cornel et al. [27]
(OR, 2.24; 95% CI, 1.15-4.16; P = 0.01). In the study by
Angerpointer et al. [42] different control groups were
used. The comparison with one group of control infants
with esophageal atresia, Hirschsprung’s disease, ompha-
locele and gastroschisis showed a significant association
between smoking at least five cigarettes per day and
ARM (OR, 2.92; 95% CI, 1.16-7.37). A similar trend was
observed when using another control group of infants
with esophageal atresia, stenosis/atresia of the small and
large bowel, Hirschsprung’s disease, omphalocele and
gastroschisis (OR, 2.30; 95% CI, 1.00-5.31). In contrast,
no association at all was observed in analyses for any
maternal smoking, regardless of the control group used.
Honein et al. [31] observed a marginally increased risk
for the maternal consumption of 6-10 cigarettes per day
(PR, 1.38; 95% CI, 1.00-1.90). The remaining studies
could not confirm an association. Only two reviewed
studies examined the association with paternal tobacco
consumption. A significant association was observed by
v a nR o o i je ta l .[ 3 9 ]( O R ,1 . 8 ;9 5 %C I ,1 . 1 - 2 . 9 ;P=0 . 0 1 )
whereas the study by Yuan et al. [30] could neither con-
firm this finding nor an association of ARM with smok-
ing of both parents.
The result of the meta-analysis on the association
between any maternal cigarette consumption and ARM
infants is shown in figure 2. From the study by Anger-
pointer et al. [42] we used the OR calculated with the
group of control infants with esophageal atresia, steno-
sis/atresia of the small and large bowel, Hirschsprung’s
disease, omphalocele and gastroschisis. The I² statistic
indicated heterogeneity across studies (c²=8 . 7 2 ;P=
0.12; I² = 42.6%). The estimated heterogeneity variance
was tau² = 0.0284. No significant association was
observed in pooled analyses using the random effects
model (OR, 1.03; 95% CI, 0.83-1.29; P = 0.77). There
was no evidence of publication bias (Kendall’st a u=
-0.56, P = 0.57; Egger’s t value = 0.32, P = 0.77).
The result of the meta-analysis on the association
between any paternal cigarette consumption and ARM
infants is shown in figure 3. The I² statistic indicated low
heterogeneity across the two studies (c² = 1.21; P = 0.27;
I² = 17.5%). In meta-analysis, a weak association was
found for any paternal cigarette consumption using a fixed
effects model (OR, 1.53; 95% CI, 1.04-2.26; P = 0.03).
Alcohol consumption
Among four studies assessing maternal alcohol consump-
tion, the association with ARM was significant only in the
one by Yuan et al. [30] (OR, 4.77; 95% CI, 1.39-16.38)
(table 3). The closer examination of alcohol quantity by
Miller et al. [37] (no use, light use [≤ 1.5 drinks per day],
heavy use [> 1.5 drinks per day] and binge drinking [≥5
drinks on at least one occasion]) did not show any indica-
tion of a possible dose-response relationship.
The result of the meta-analysis on the association of any
maternal alcohol consumption with ARM is shown in
figure 4. The I² statistic indicated heterogeneity across
studies (c² = 6.74; P = 0.08; I² = 55.5%). The estimated
heterogeneity variance was tau² = 0.1172. No significant
association was observed in pooled analyses using the ran-
dom effects model (OR, 1.17; 95% CI, 0.71-1.91; P = 0.55).
There was no evidence of publication bias (Kendall’st a u=
1.36, P = 0.17; Egger’s t value = 1.37, P = 0.30).
Caffeine intake
Only the study by Miller et al. [37] reported on a poten-
tial role of caffeine exposure (table 4). Although ARM
was more common among children of mothers report-
ing on a periconceptional use of caffeine, the association
was statistically significant for the intermediate exposure
group 100-299 mg only (OR, 1.9; 95% CI, 1.2-3.0).
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Page 4 of 16Table 1 Case-control and cross-sectional studies reporting on the association of ARM and environmental risk factors
Study population
No.
participants
Ref. First author, year Country Cases Controls Age range Setting,
control type
Data acquisition (period) Assessed risk factor(s)
[25] Bánhidy, 2010 Hungary 231 38,151 < 19 - > 35 population-
based,
no birth defects
data from the Hungarian
Case-Control Surveillance
of Congenital Abnormalities
(1980-1996)
diabetes
[26] Blomberg,
2010
¥
Sweden 401 1,049,181 < 20 - ≥45 population-
based,
all infants
data from the Swedish
Medical Birth Registries
†
(1995-2007)
overweight/obesity
[35] Herdt-Losavio,
2010
USA 328 3,833 < 20 - ≥35 multistate
population-
based,
no birth defects
data from the National Birth
Defects
Prevention Study (NBDPS)
(1997-2003)
occupational hazard
[39] van Rooij,
2010
Netherlands 85 650 ≥35 hospital-based,
no major birth
defects
questionnaire (1996-2008
‡) smoking, alcohol,
overweight/obesity,
occupational hazard
[37] Miller, 2009 USA 464,
216
#
4,940 ≤ 19 - ≥35 multistate
population-
based,
no major birth
defects
data from the National Birth
Defects
Prevention Study (NBDPS)
(1997-2003)
smoking, alcohol, caffeine
[41] van Gelder,
2009
USA 456-
468
4,967 < 20 - ≥35 multistate
population-
based,
no major birth
defects
data from the National Birth
Defects
Prevention Study (NBDPS),
collected by
telephone interview (1997-
2003)
illicit drugs of mothers
(between one month
before pregnancy
and the end of the third
month of pregnancy)
[34] Correa, 2008 USA 230
200
#
4,689 < 20 - ≥35 multistate
population-
based,
no major birth
defects
data from the National Birth
Defects
Prevention Study (NBDPS)
(1997-2003)
diabetes
[1] Forrester,
2007
USA 162 316,346 N.A. state-wide
population-
based,
all live births
data from the Hawaii Birth
Defects
Program (HBDP), collected
through review
of medical records (1986-
2002)
illicit drugs of mothers
(during
pregnancy and 1 year
after delivery)
[32] Frías, 2007
¥ USA 417
Δ,
427
ΔΔ
29,722
Δ,
30,509
ΔΔ
N.A. hospital-based,
other
malformed
infants
data from the Spanish
Collaborative Study of
Congenital Malformations
(ECEMC) (1976-2005)
diabetes
[40] Waller, 2007 USA 380,
77
#
4,065 < 18 - ≥35 multistate
population-
based,
no birth defects
data from the National Birth
Defects
Prevention Study (NBDPS)
(1997-2002)
overweight/obesity
[7] Correa, 2003 USA 56,
32
#
3,029 < 20 - ≥30 population-
based,
no birth defects
data from the Metropolitan
Atlanta Congenital
Defects Program (MACDP)
(1968-1980)
diabetes
[24] Aberg, 2001 Sweden 15 600 N.A. population-
based,
other
malformed
infants
data from the Swedish
Medical Birth Registries
†
(1987-1997)
diabetes
[31] Honein, 2001 USA 564 6,160,942 < 30 - ≥30 population-
based,
all live births
US public-use natality data
tapes
(National Vital Statistics
System, National
Centre for Health Statistics)
(1997-1998)
smoking
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Two studies reported on the association with maternal
periconceptional illicit drug use (table 5). Results were
inconsistent with tentatively reduced risks in the study
by van Gelder et al. [41] and increased risks in the study
by Forrester and Merz [1]. Due to the small sample size,
confidence intervals were very wide in both studies.
Nevertheless, significantly increased risks were found by
Forrester and Merz [1] for marijuana use (OR, 10.57;
95% CI, 2.87-38.96) as well as for cocaine use (OR, 6.01;
95% CI, 1.05-34.27).
Body weight
Three studies reported on the association between
maternal pre-pregnancy obesity (BMI ≥30) and ARM
(table 6). Risks were consistently increased in two stu-
dies (Blomberg and Källén [26]: OR, 1.87; 95% CI, 1.42-
2.47; Waller et al. [40]: OR, 1.46; 95% CI, 1.10-1.95). By
Table 1 Case-control and cross-sectional studies reporting on the association of ARM and environmental risk factors
(Continued)
[36] Martínez-Frías,
1998
¥
Spain 227 19,377 N.A. hospital-based,
other
malformed
infants
data from the Spanish
Collaborative Study of
Congenital Malformations
(ECEMC) (1976-1995)
diabetes
[38] Stoll, 1997 France 108,
51
#
108 F: mean age
26.9,
M: mean age
29.9
hospital-based,
no birth defects
interview (1979-1995) smoking, alcohol,
diabetes,
X-ray examinations
[27] Cornel, 1996 Netherlands 52 3,962 ≤ 20 - ≥40 population-
based,
other
malformed
infants
data from the Northern
Netherlands
(NNL) (1981-1994)
smoking
[29] Schnitzer,
1995
USA 70 2,279 F: < 20 - ≥40,
M: < 20 - ≥45
population-
based,
no birth defects
data from the Metropolitan
Atlanta Congenital
Defects Program (MACDP)
(1968-1980)
occupational hazard
[30] Yuan, 1995 Japan 84,
49
#
174 F: 29.1 ± 4.9,
M: 32.1 ± 5.6
population-
based,
no birth defects
data from the Kanangawa
Birth Defects
Monitoring Program (KAMP)
(1989-1994)
smoking, alcohol
[43] Martínez-Frías,
1994
¥
Spain 196 18,563 N.A. hospital-based,
other
malformed
infants
data from the Spanish
Collaborative Study of
Congenital Malformations
(ECEMC) (1976-1992)
diabetes
[28] Matte, 1993 USA 103 2,403 < 20 - > 35 population-
based,
no birth defects
data from the Metropolitan
Atlanta Congenital
Defects Program (MACDP)
(1968-1980)
occupational hazard
[33] Shiono, 1986 USA 14 578 N.A. population-
based,
other
malformed
infants
data from the Kaiser-
Permanente
Birth Defects Study (1974-
1977)
smoking
[42] Angerpointer,
1981
Germany 78
78
78
78
210*
169**
75***
53****
< 20 - > 40 hospital-based,
other
malformed
infants
questionnaire (1970-1974) smoking
# ARM infants with isolated (no additional major defects) anomaly.
† The Swedish Medical Birth Registry, the Swedish Register of Birth Defects (previously called the Registry of Congenital Malformations) and the National Patient
Register (previously called the Hospital Discharge Registry).
‡ Difference in case and control period: cases 1996-2008, controls 1996-2004.
Δ ARM infants for the examination of maternal pre-gestational diabetes.
ΔΔ ARM infants for the examination of maternal gestational diabetes.
* Control group includes 41 infants with esophageal atresia, 41 with stenosis/atresia of the small and large bowel, 75 with Hirschsprung’s disease, 28 with
omphalocele and 25 with gastroschisis.
** Control group includes 41 infants with esophageal atresia, 75 with Hirschsprung’s disease, 28 with omphalocele and 25 with gastroschisis.
*** Control group includes 75 infants with Hirschsprung’s disease.
**** Control group includes 28 infants with omphalocele and 25 with gastroschisis.
¥ Cross-sectional study.
M = male; F = female; BMI = body mass index; N.A. = not available.
Zwink et al. Orphanet Journal of Rare Diseases 2011, 6:25
http://www.ojrd.com/content/6/1/25
Page 6 of 16categorizing maternal obesity into three classes (adiposi-
tas I [BMI 30-34.9], adipositas II [BMI 35-39.9] and
morbid obesity [BMI ≥40]), the closer examination by
B l o m b e r ga n dK ä l l é n[ 2 6 ]s h o w e dap a r t i c u l a r l ys t r o n g
risk increase of ARM for morbid obesity (OR, 3.72; 95%
CI, 1.70-7.07). Among three studies assessing maternal
overweight, a significant association with ARM was
observed only in van Rooij et al. [39] (OR, 1.8; 95% CI,
1.1-3.0). No such association was seen with paternal
overweight in this study (OR, 0.8; 95% CI, 0.5-1.3).
The result of the meta-analysis on the association of
maternal underweight with ARM is shown in figure 5.
The I² statistic indicated low heterogeneity across the
two studies (c² = 1.01; P = 0.32; I² = 0.5%). No signifi-
cant association was observed in pooled analyses using
the fixed effects model (OR, 0.96; 95% CI, 0.65-1.43;
P = 0.85).
The result of the meta-analysis on the association of
maternal overweight with ARM is shown in figure 6.
The I² statistic indicated low heterogeneity across the
three studies (c² = 2.25; P = 0.32; I² = 11.3%). In meta-
analysis, a weak association was found for maternal
overweight using a fixed effects model (OR, 1.25; 95%
CI, 1.07-1.47; P = 0.0054). There was no evidence of
Table 2 Associations between periconceptional exposures to tobacco
Maternal smoking Paternal smoking Smoking of
both parents
Ref. First author, year Exposure OR [95% CI] P
value
OR [95% CI] P
value
OR [95% CI] Adjustment/
matching factors
[39] van Rooij,
2010
Cigarette consumption
before or during pregnancy
0.8 [0.5, 1.3] 0.61 1.8 [1.1, 2.9]
§ 0.01 - -
[37] Miller, 2009
§§ Non-smoker not exposed to
ETS
Non-smoker exposed to ETS
at home or work
Non-smoker exposed to ETS
at home and work
Smoked < 0.5 pack/day
Smoked ≥0.5 pack/day
Any smoking
1.0 Reference
1.1 [0.8, 1.5]
1.4 [0.5, 4.0]
1.0 [0.5, 1.8]
1.2 [0.8, 1.7]
1.1 [0.8, 1.6]
- - - None of the variables
met the criteria
for confounding by
the author; therefore,
only the unadjusted
odds
ratios were presented
[31] Honein, 2001 Any smoking
1-5 cigarettes/day
6-10 cigarettes/day
11-20 cigarettes/day
≥21 cigarettes/day
PR: 1.19 [0.94,
1.50]
PR: 0.95 [0.60,
1.50]
PR: 1.38 [1.00,
1.90]
PR: 1.19 [0.80,
1.79]
PR: 0.94 [0.29,
2.98]
- - - Adjusted for: maternal
age,
education and race/
ethnicity
[38] Stoll, 1997 Any smoking 0.98 [0.94, 1.02] - - - -
[27] Cornel, 1996 Any smoking 2.24 [1.15, 4.16] 0.01 - - -
[30] Yuan, 1995 Any smoking - - 1.14 [0.59, 2.18] 0.70 1.75 [0.63,
4.87]
Matched by: maternal
age groups
(5-years interval), sex,
parity
and season of birth
[33] Shiono, 1986 Any smoking 0.41 [0.09, 1.87] 0.25 - - -
[42] Angerpointer,
1981
Any smoking
≥5 cigarettes per day
0.95 [0.45, 1.99]*
0.99 [0.46, 2.14]
†
1.20 [0.47, 3.10]
‡
0.63 [0.25, 1.57]
#
2.30 [1.00, 5.31]*
2.92 [1.16, 7.37]
†
1.58 [0.51, 4.83]
#
0.89
0.98
0.70
0.32
-
-- -
* Control group includes 41 infants with esophageal atresia, 41 with stenosis/atresia of the small and large bowel, 75 with Hirschsprung’s disease, 28 with
omphalocele and 25 with gastroschisis.
† Control group includes 41 infants with esophageal atresia, 75 with Hirschsprung’s disease, 28 with omphalocele and 25 with gastroschisis.
‡ Control group includes 75 infants with Hirschsprung’s disease.
# Control group includes 28 infants with omphalocele and 25 with gastroschisis.
§ Paternal cigarette consumption 3 months before conception.
§§ Exposure during the month before pregnancy to the third month of pregnancy.
ETS = environmental tobacco smoke; PR = prevalence ratio.
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value = 3.01, P = 0.20).
The result of the meta-analysis on the association of
maternal obesity with ARM is shown in figure 7. The I²
statistic indicated homogeneity across the three studies
(c² = 1.64; P = 0.44; I² = 0%). In meta-analysis, a signifi-
cant association was found for maternal obesity using a
fixed effects model (OR, 1.64; 95% CI, 1.35-2.00; P <
0.0001). There was no evidence of publication bias
(Kendall’s tau = -0.52, P = 0.60; Egger’s t value = -0.36,
P = 0.78).
Diabetes
Among eight studies assessing maternal diabetes, six dif-
ferentiated between pre-existing and gestational diabetes
(table 7). The closer examination of results for pre-exist-
ing diabetes showed a significantly increased risk in the
study by Frías et al. [32] (OR, 2.87; 95% CI, 1.20-6.87;
P = 0.04). Correa et al. [34] and Aberg et al. [24] could
confirm this finding (OR, 4.70; 95% CI, 1.55-14.26 and
OR, 8.18; 95% CI, 3.86-17.34; P < 0.00001) and also
observed a significant association with gestational dia-
betes (OR, 1.91; 95% CI, 1.02-3.56 and OR, 3.29; 95%
CI, 1.63-6.63; P = 0.0008). Among four studies that
reported on the association with any maternal diabetes,
both studies by Correa et al. [7,34] found a significantly
increased risk (OR, 2.15; 95% CI, 1.31-3.55 and OR,
4.32; 95% CI, 1.50-12.47). Due to the small sample size,
confidence intervals were very wide in all eight studies.
The result of the meta-analysis on the association of
any maternal diabetes mellitus with ARM is shown in
figure 8. The I² statistic indicated high heterogeneity
across the four studies (c² = 26.99; P < 0.0001; I² =
88.9%). The estimated heterogeneity variance was tau² =
1.0416. No significant association was observed in
pooled analyses using the random effects model (OR,
1.01; 95% CI, 0.33-3.12; P = 0.99). There was no evi-
dence of publication bias (Kendall’st a u=0 . 0 ,P=1 . 0 ;
Egger’s t value = -0.92, P = 0.45).
The result of the meta-analysis on the association of
maternal pre-gestational diabetes with ARM is shown in
figure 9. The I² statistic indicated moderate heterogene-
ity across the four studies (c² = 4.13; P = 0.25; I² =
27.4%). The estimated heterogeneity variance was tau² =
0.0929. A strong association was observed in pooled
analyses using the random effects model (OR, 4.51; 95%
CI, 2.55-7.97; P < 0.0001). There was no evidence of
publication bias (Kendall’s tau = -0.68, P = 0.50; Egger’s
t value = -1.15, P = 0.37).
The result of the meta-analysis on the association of
maternal gestational diabetes with ARM is shown in
figure 10. The I² statistic indicated moderate heterogeneity
Table 3 Associations between periconceptional exposures to alcohol
Maternal alcohol use Paternal
alcohol use
Ref. First
author,
year
Exposure OR [95% CI] P
value
Exposure OR [95% CI] P
value
Adjustment/matching
factors
[39] van
Rooij,
2010
Alcohol consumption before
or during pregnancy
1.0 [0.6, 1.5] 1.0 Alcohol
consumption
three
months before
conception
1.3 [0.7, 2.5] 0.33 -
[37] Miller,
2009*
Non-drinker
Average ≤ 1.5 drink/day
Average > 1.5 drink/day
≥5 alcoholic drinks
Drank any alcohol
1.0 Reference
1.0 [0.7, 1.5]
1.2 [0.9, 1.6]
0.9 [0.6, 1.6]
0.9 [0.7, 1.2]
- - - - None of the variables met
the criteria
for confounding by the
author; therefore,
only the unadjusted odds
ratios were presented
[38] Stoll,
1997
Any alcohol 1.25 [0.07, 21.04] - - - - -
[30] Yuan,
1995
Any alcohol 4.77 [1.39, 16.38] - - - - Matched by: maternal age
groups (5-years interval),
sex, parity and season of birth
* Exposure during the month before pregnancy to the third month of pregnancy.
Table 4 Associations between periconceptional exposures
to caffeine intake
Maternal caffeine
exposure*
Ref. First
author,
year
Exposure OR [95% CI] Adjustment/matching
factors
[37] Miller,
2009
<1 0m g
10-99 mg
100-299 mg
≥300 mg
1.0
Reference
1.4 [0.9, 2.3]
1.9 [1.2, 3.0]
1.5 [0.9, 2.7]
None of the variables
met the criteria for
confounding by the
author; therefore, only
the unadjusted odds
ratios were presented
* Caffeine intake per day in the year before pregnancy.
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Page 8 of 16across the five studies (c² = 5.71; P = 0.22; I² = 30.0%). The
estimated heterogeneity variance was tau² = 0.0570. In
meta-analysis, a significant association was found for
maternal gestational diabetes using a random effects
model (OR, 1.81; 95% CI, 1.23-2.65; P = 0.0025). There
was no evidence of publication bias (Kendall’s tau = 0.98,
P = 0.33; Egger’s t value = 0.85, P = 0.46).
Occupational hazard
Five studies reported on a potential role of maternal and
paternal occupational hazards (table 8). Herdt-Losavio et
al. [35] found a significantly increased risk with maternal
janitors and cleaners (OR, 1.82; 95% CI, 1.06-3.10) and
maternal scientists (OR, 2.38; 95% CI, 1.24-4.55) and
Schnitzer et al. [29] with paternal vehicle manufacturers
(OR, 5.1; 95% CI, 1.3-19.2). Van Rooij et al. [39] showed
a suggestive association with ARM for maternal contact
with industrial cleaning agents and solvents during preg-
nancy (OR, 2.9; 95% CI, 0.9-9.3) and for paternal contact
with exhaust fumes three months before conception
(OR, 1.9; 95% CI, 1.0-3.6). A significant inverse associa-
tion with maternal exposure to X-ray examinations was
reported in the study by Stoll et al. [38] (OR, 0.19; 95%
CI, 0.09-0.38). Due to the small sample size, confidence
intervals were very wide in the studies by Herdt-Losavio
et al. [35], Matte et al. [28], Schnitzer et al. [29] and van
Rooij et al. [39].
Discussion
This systematic review and meta-analysis summarized
the results of 22 studies on the association between pre-
natal environmental risk factors and infants born with
an anorectal malformation reported between 1981 and
June 2010. The majority of the studies were conducted
in the United States. Case numbers ranged from 14
ARM cases in the study by Shiono et al. [33] to 564
ARM cases in the study by Honein et al. [31]. Studies
were also heterogeneous with respect to control selec-
tion and adjustment for covariates. Meta-analysis was
done for risk factors reported on in at least two studies,
Table 5 Associations between periconceptional exposures to illicit drugs
Maternal illicit drug use
Ref. First author,
year
Exposure OR [95% CI] Adjustment/matching factors
[41] van Gelder,
2009*
Cannabis use
Cocaine use
0.7 [0.4, 1.2]
0.4 [0.1, 2.7]
Adjusted for: maternal age at delivery, race or ethnicity,
level of education, cigarette smoking, binge drinking,
pregnancy BMI and periconceptional folic acid use
Stimulant use 1.1 [0.3, 3.8] Adjusted for: maternal age at delivery, level of education,
binge drinking, pregnancy BMI and periconceptional
folic acid use
[1] Forrester,
2007
§†
Methamphetamine use
Cocaine use
Marijuana use
3.19 [0.87, 11.73]
6.01 [1.05, 34.27]
10.57 [2.87,
38.96]
-
* Exposures at any time between one month before pregnancy and the end of the third month of pregnancy (periconceptional period).
§ Exposures during pregnancy and 1 year after delivery.
† Study reported on the ratio of the rate of illicit drug use among birth defect cases to the rate of illicit drug use among all deliveries. *We calculated the
corresponding OR by data given in the article.
Table 6 Associations between periconceptional exposures to body weight
Maternal overweight/obesity
Ref. First author, year Exposure OR [95% CI] Adjustment/matching factors
[26] Blomberg, 2010 BMI < 18.5
BMI 18.5 - 24.9
BMI 25 - 29.9
BMI ≥30
1.22 [0.63, 2.13]
1.00 Reference
1.21 [0.98, 1.51]
1.87 [1.42, 2.47]
Adjusted for: maternal age, parity, smoking in early pregnancy
and year of birth using the Mantel-Haenszel
method
BMI 30 - 34.9
BMI 35 - 39.9
BMI ≥40
1.77 [1.29, 2.44]
1.48 [0.74, 2.64]
3.72 [1.70, 7.07]
Adjusted for: see above
[39] van Rooij, 2010** BMI 25 - 29.9
BMI ≥30
1.8 [1.1, 3.0]
1.4 [0.6, 3.2]
N/A*
[40] Waller, 2007 BMI < 18.5
BMI 25 - 29.9
BMI ≥30
0.81 [0.48, 1.36]
1.19 [0.92, 1.55]
1.46 [1.10, 1.95]
Adjusted for: maternal age, ethnicity, education, parity,
smoking in the month prior to conception and supplemental
folic acid intake in the month prior to conception
* The association was not confounded by any covariable.
** More detailed information on the results was obtained directly through the author.
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Page 9 of 16i.e. maternal and paternal smoking, maternal alcohol
consumption, underweight, overweight, obesity, any
maternal diabetes mellitus, pre-gestational and gesta-
tional diabetes. Consistently increased risks were
observed for paternal smoking, maternal overweight,
obesity and diabetes, but not for maternal smoking and
alcohol consumption.
There is a great discrepancy in the reported results on
the associations between maternal illicit drug use and
ARM which impede comparability. Closer examination
of the studies suggests that different data collection
could lead to these different results. In the study by van
Gelder et al. [41], mothers were interviewed by tele-
phone by trained interviewers using a standardized
questionnaire. Forrester and Merz [1] used register-
b a s e dd a t af r o mt h eH a w a i iB i r t hD e f e c t sP r o g r a m
where trained staff collected information on cases
through review of medical records. Thus, only consump-
tion that had to be severe enough to be recorded in rou-
tine medical records was ascertained. It appears
conceivable that illicit drug use might have been asked
for and recorded more often among mothers of children
with malformations than among other mothers. The
discrepancy found on the associations between maternal
exposures to X-rays may likewise be partly resulting
from different exposure definitions. Van Rooij et al. [39]
examined the maternal occupational hazard to X-rays
during pregnancy whereas Stoll et al. [38] assessed
women’s own X-ray examinations during pregnancy.
When available, data on ARM infants with isolated
anomalies (no additional major defects) were preferred
in this review to data on ARM infants with multiple
defects. Only six of the 22 reviewed studies looked at
both groups [7,30,34,37,38,40]. Analyses, however,
showed nearly the same results. Furthermore, two stu-
dies by Martínez-Frías et al. [44] and Sharpe et al. [45]
were excluded because they grouped ARM with other
congenital malformations (among others intestinal and
tracheo-esophageal atresias) which might mix or dilute
potential effects in case of diverse etiologies. The
excluded studies did not find an association with the
examined risk factors. In contrast, although Honein et
al. [31] reported on the examination of “rectal atresia”,a
very rare subgroup of ARM, we included this study
because it appears that the term of “rectal atresia” was
used synonymously for ARM, given that the reported
Table 7 Associations between periconceptional exposures to diabetes mellitus
Maternal diabetes mellitus
Ref. First author, year Exposure OR [95% CI] P value Adjustment/matching factors
[25] Bánhidy, 2010 Gestational diabetes 2.2 [0.7, 6.8] - Adjusted for: maternal age and employment status, birth
order and maternal hypertension
[34] Correa, 2008 Diabetes mellitus**
Pre-gestational
diabetes
Gestational diabetes
2.15 [1.31, 3.55]
4.70 [1.55, 14.26]
1.91 [1.02, 3.56]
0.005
-
-
Adjusted for: maternal age, race/ethnicity, entry into
prenatal
care, BMI, study center and household income
[32] Frías, 2007* Diabetes mellitus**
Pre-gestational
diabetes
Gestational diabetes
1.43 [0.92, 2.25]
2.87 [1.20, 6.87]
1.18 [0.71, 1.98]
0.13
0.04
0.48
-
[24] Aberg, 2001 Pre-gestational
diabetes
Gestational diabetes
8.18 [3.86, 17.34]
3.29 [1.63, 6.63]
< 0.00001
0.0008
-
[7] Correa, 2003 Diabetes mellitus 4.32 [1.50, 12.47] - Adjusted for: infant’s period of birth, maternal race, age,
education, prenatal cigarette smoking and prenatal alcohol
consumption
[36] Martínez-Frías, 1998 Gestational diabetes 1.51 [0.60, 3.55]
1.56 [0.49, 4.40]
†
1.27 [0.20, 5.54]
‡
1.70 [0.67, 3.98]
#
4.19 [0.66, 26.74]
§
--
[38] Stoll, 1997 Diabetes mellitus 0.01 [0.02, 1.38] - -
[43] Martínez-Frías,
1994*
Pre-gestational
diabetes
2.57 [0.69, 9.60] 0.19 -
* Studies reported on the quotient of congenital anomaly frequencies only (frequency ratio: FR). We calculated the corresponding OR by data given in the
articles.
** Studies reported on pre-gestational and gestational diabetes. We calculated the OR for any diabetes mellitus by data given in the articles.
† Restricted to: maternal age (≤ 34 years).
‡ Restricted to: maternal age (≥35 years).
# Restricted to: non-consanguineous parents.
§ Restricted to: insulin treatment.
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for rectal atresia and Honein et al. [31] compared their
results with other studies reported on ARM. In general,
there is no unique terminology for ARM that is used in
the literature. Besides anorectal malformation, terms of
anal atresia, anorectal atresia and imperforate anus can
be found for this anomaly. Even ARM itself is a mixed
group with isolated and associated malformations ran-
ging from lower to higher forms with different genetic
background [46].
Looking at some other gastro-intestinal malformations,
maternal diabetes also seems to be a risk factor for eso-
phageal atresia [25,32,34]. However, no clear association
was found with gastroschisis, omphalocele, small-intestinal
atresia and duodenal atresia [32,34,36,43]. There is a sug-
gestive association between maternal overweight and
omphalocele [40], but not for the other defects. Maternal
obesity also seems to be a risk factor for omphalocele,
whereas an inverse association was found for gastroschisis
[47,48]. The use of illicit drugs including cocaine,
methamphetamines and marijuana during pregnancy was
found to be associated with increased risk of gastroschisis
[47] and the use of cocaine, amphetamines, decongestants
and pseudoephedrine was associated with intestinal atresia
[49-51]. Consistently increased risks for maternal smoking
were only observed for pyloric stenosis [52]. For omphalo-
cele and gastroschisis, no consistently increased risks were
found regarding alcohol consumption [47].
The significant associations with ARM and some other
gastro-intestinal malformations show that the rise in
maternal overweight and obesity, as well as diabetes
during the last decades are of relevance for these birth
Table 8 Associations between periconceptional exposures to occupational hazard
Maternal occupational
hazard*
Paternal occupational hazard**
Ref. First author,
year
Exposure OR [95% CI] Exposure OR [95% CI] Adjustment/matching factors
[39] van Rooij,
2010
Industrial cleaning agents
and solvents
Cytostatics
X-rays
2.9 [0.9, 9.3]
1.5 [0.3, 6.9]
0.6 [0.1, 2.6]
Adjusted for: family history of ARM
and paternal smoking
-
Adjusted for: maternal multivitamin
use
Industrial cleaning
agents and solvents
Paint/varnish/adhesives/
ink/thinner
Welding fumes
Exhaust fumes
0.6 [0.2, 1.7]
1.4 [0.6, 3.7]
1.3 [0.5, 3.3]
1.9 [1.0, 3.6]
Adjusted for: family history of ARM,
maternal BMI before pregnancy,
paternal smoking
and paternal job exposure to
exhaust fumes
Adjusted for: family history of ARM
Adjusted for: family history of ARM
and paternal job exposure to
exhaust fumes
-
[35] Herdt-
Losavio,
2010
Janitors, cleaners
Scientists
1.82 [1.06, 3.10]
***
2.38 [1.24, 4.55]
***
- - Adjusted for: study centre, folic acid
use,
maternal age at delivery, maternal
pre-pregnancy
BMI, maternal race/ethnicity,
maternal education,
parity, maternal smoking and
maternal alcohol use
during the first trimester
[38] Stoll, 1997 X-rays
† 0.19 [0.09, 0.38] - - -
[29] Schnitzer,
1995
- - Carpenters,
woodworkers
Electricians, electrical
workers
2.4 [0.7, 8.5]
1.7 [0.6, 5.0]
Matched for: race, year and hospital
of birth
Matched for: see above
Printers
Policemen, guards
Vehicle manufacturers
2.9 [0.8, 10.2]
2.9 [0.8, 9.9]
5.1 [1.3, 19.2]
Adjusted for: maternal age and
education
Adjusted for: see above
Adjusted for: see above
[28] Matte,
1993
Nursing occupations 2.15 [0.83, 5.58] - - -
* Job exposure during pregnancy.
** Job exposure 3 months before conception.
*** Job exposure 1 month prior to conception through the end of the third month of pregnancy.
† Exposure to X-ray examinations.
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Page 11 of 16defects. For example, the prevalence of overweight (obe-
sity) in adult females from the Netherlands increased
from 30% (6%) in 1981 to 42% (12%) in 2004 [53]. In
girls, overweight (obesity) prevalence doubled or even
tripled from 1980 to 1997 and again from 1997 to 2002-
2004. The same trend was observed in the United States
where 17.9% of all school-age girls were overweighed
(11.7% obese) in 1999-2000 and 22.3% were overweighed
(13.6% obese) in 2003-2004 [54]. During the same time,
the number of women with diabetes was also increasing.
The worldwide prevalence of type 1 and type 2 diabetes
in women has doubled since the 1980s [55,56]. The
overall prevalence was estimated to be 2.2% worldwide
in 1995 and is expected to be 2.8% in 2025 with a
higher proportion in the developed countries than in
the developing countries (3.6% vs. 1.7% in 1995; 4.5% vs.
2.5% in 2025) [57]. Previous studies underline the need
of substantial efforts to limit the obesity epidemic,
which is also the main cause of the growing prevalence
of diabetes among women in child-bearing age [58,59].
Besides many other beneficial health effects, such efforts
could substantially reduce the risk of ARM and other
birth defects in the offspring. Although associations of
maternal smoking and alcohol consumption with ARM
do not seem to be established based on existing
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Figure 2 Forest plot for maternal cigarette consumption.
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Figure 3 Forest plot for paternal cigarette consumption.
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Figure 4 Forest plot for maternal alcohol consumption.
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Page 12 of 16evidence, the adverse health effects of these habits on
the embryonic development underline the importance of
avoiding them throughout pregnancies and beyond.
Our review has a number of limitations mostly result-
ing from the overall scarcity of published evidence. First,
our meta-analysis was limited by the data provided in
the individual studies. Not all studies provided risk esti-
mates adjusted for potentially influential confounders,
such as maternal age, ethnicity, education, parity, peri-
conceptional smoking and folic acid intake [40] or
maternal age, race/ethnicity, education, smoking, binge
drinking, pregnancy BMI and periconceptional folic acid
use [41]. Analyses of diabetes were only adjusted for
BMI in the study by Correa et al. [34], known as poten-
tial influential confounder. Due to the small number of
studies, we decided to pool adjusted and crude values
for meta-analyses. Second, some studies used affected
(malformed) control groups. Other studies used mixed
controls of live-born malformed and healthy babies. A
potential advantage of using malformed controls is
potential reduction of response bias or recall bias that
may occur when a non-malformed control group is
used. On the other hand, observed associations may be
biased if the risk factors of interest are also associated
with the malformations of controls. Third, most sample
sizes were small, so the power to detect associations was
low. Fourth, despite the lack of indication of major pub-
lication bias, it is impossible to be ruled out completely,
especially in the light of the low number of studies.
Finally, although we searched in four databases
( P u b M e d ,E M B A S E ,I S IW e bo fK n o w l e d g ea n dt h e
Cochrane library) and completed our search by review-
ing related and cross-referencing literature, existence of
relevant missing studies cannot be excluded.
To our knowledge, our article is the first systematic
review and meta-analysis that provides an overview of
the few available studies that reported on the association
between prenatal environmental risk factors of the par-
ents and ARM. Adequate evidence is still very limited.
Therefore, further multicentero rr e g i s t e r - b a s e ds t u d i e s
are needed to clarify the role of key risk factors for the
development of ARM. One example is the recent estab-
lishment of the German Network for Congenital Uro-
REctal Malformations (CURE-Net). The aim of this con-
sortium is to collect data of affected newborns as well as
of older patients with an anorectal malformation (ARM)
or an exstrophy-epispadias complex (EEC) that allow to
investigate molecular causes, clinical implications and
psychosocial outcomes. For a standardized description
of diagnostic subgroups, international classifications are
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1.21 (0.98, 1.51)
1.8 (1.1, 3.0)
1.19 (0.92, 1.55)
1.25 (1.07, 1.47), P=0.0054
1.26 (1.06, 1.50), P=0.009
01234
Total: Random effects
Total: Fixed effects
Waller et al., 2007
van Rooij et al., 2010
Blomberg and Källén, 2010
Figure 6 Forest plot for maternal overweight (BMI 25-29.9).
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Figure 5 Forest plot for maternal underweight (BMI < 18.5).
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Figure 7 Forest plot for maternal obesity (BMI ≥30).
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Figure 8 Forest plot for any maternal diabetes mellitus.
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Figure 9 Forest plot for maternal pre-gestational diabetes.
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Figure 10 Forest plot for maternal gestational diabetes.
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Page 14 of 16used (Krickenbeck for ARM [60] and Gearhart & Jeffs
for EEC [61]). Associated malformations are collected
with means of the London Dysmorphology Database
[62] and environmental risk factors according to the
core dataset of surveillance of congenital anomalies in
Europe (EUROCAT) [63]. Nationwide data acquisition
should enable to achieve a sample size that is large
enough to clarify the role of key risk factors for the
development for ARM and EEC in general but also for
each subgroup separately. Furthermore, activities are
ongoing aiming to expand such a register on an interna-
tional level. The recently established International Con-
sortium on Anorectal Malformations (ARM-Net), a
European collaboration between France, Italy, Germany
and the Netherlands, aims to identify genetic and envir-
onmental risk factors by data sharing and combined
research activities [64]. Both consortia offer the unique
opportunity to establish a basis for future research to
overcome current scarcity of evidence in the field of
ARM, especially from populations outside the United
States.
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